InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Explore the complete record of transactions filed by Jewell Christopher M. Director active across 1 company, notably Cartesian Therapeutics, Inc.. In total, 6 reports have been published. Breakdown: 0 buy · 1 sell. Total volume traded: €21k. History available since 2 January 2024. The latest transaction was filed on 10 January 2025 (Levée d'options). Regulator: SEC (Form 4). The full history is openly available.
6 of 6 declarations